
Eric Schuur, co-founder and CEO of HepaTx, discusses the science behind groundbreaking stem cell therapies. We also explore the potential of such therapies to change how we fight all diseases.
Jan 22, 2023
15 min

David Mack, co-founder and CEO of PMV Pharma, gives us an in-depth look at the cancer-stopping power of P53. We discuss emerging cancer therapies, small-molecule chemistry, and future drug targets. Plus, fun stories from the invention of PCR.
Jul 27, 2022
36 min
